Robert Connelly
- Role
- CEO at Elicio Therapeutics
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Robert Connelly
Robert Connelly is a prolific entrepreneur and leader with more than 30 years of…
Experience
CEO
Oct 2018 — Present
Elicio Therapeutics, based in Cambridge MA, is committed to transforming the lives of patients and their families by re-engineering the body’s immune response to defeat cancer. By combining expertise in materials science and immunology, Elicio is engineering potent vaccines and immuno-therapies for an array of aggressive cancers. Elicio was founded to expand and apply the ground-breaking Amphiphile technology invented and developed by Darrell Irvine PhD, Professor of Biological Engineering and Materials Sciences and Howard Hughes Investigator at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. Elicio’s lead Amphiphile vaccines targeting pancreatic, colorectal and head and neck cancers will begin initial patient studies in the first half of 2020. For more information please visit
Skills
- Clinical Trials
- Biotechnology
- Biochemistry
- Drug Delivery
- Clinical Development
- Cancer
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.